EP0711341A4 - Receptor function assays - Google Patents

Receptor function assays

Info

Publication number: EP0711341A4
Authority: EP; European Patent Office
Prior art keywords: receptor function; function assays; assays; receptor; function
Prior art date: 1993-07-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP94924067A

Other languages

German (de)

French (fr)

Other versions

EP0711341A1 (en

Inventor

Neill A Giese

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

COR Therapeutics Inc

Original Assignee

COR Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-29

Filing date

1994-07-29

Publication date

2001-12-19

1994-07-29 Application filed by COR Therapeutics Inc filed Critical COR Therapeutics Inc

1996-05-15 Publication of EP0711341A1 publication Critical patent/EP0711341A1/en

2001-12-19 Publication of EP0711341A4 publication Critical patent/EP0711341A4/en

Status Withdrawn legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Hematology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

EP94924067A 1993-07-29 1994-07-29 Receptor function assays Withdrawn EP0711341A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US99850		1987-09-22
US9985093A	1993-07-29	1993-07-29
PCT/US1994/008571 WO1995004136A1 (en)	1993-07-29	1994-07-29	Receptor function assays

Publications (2)

Publication Number	Publication Date
EP0711341A1 EP0711341A1 (en)	1996-05-15
EP0711341A4 true EP0711341A4 (en)	2001-12-19

Family

ID=22276905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP94924067A Withdrawn EP0711341A4 (en)	1993-07-29	1994-07-29	Receptor function assays

Country Status (6)

Country	Link
EP (1)	EP0711341A4 (en)
JP (1)	JPH09501767A (en)
AU (1)	AU7408094A (en)
CA (1)	CA2166871A1 (en)
SG (1)	SG63596A1 (en)
WO (1)	WO1995004136A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19741716A1 (en) *	1997-09-22	1999-03-25	Hoechst Ag	Recognition system
US6406869B1 (en)	1999-10-22	2002-06-18	Pharmacopeia, Inc.	Fluorescent capture assay for kinase activity employing anti-phosphotyrosine antibodies as capture and detection agents
DE10323081A1 (en) *	2003-05-22	2004-12-16	Aventis Pharma Deutschland Gmbh	Use of a polypeptide
WO2007002483A1 (en) *	2005-06-24	2007-01-04	Beckman Coulter, Inc.	Immunoassay of phosphorylated proteins
WO2009058908A2 (en)	2007-10-29	2009-05-07	Eisai R & D Management Co., Ltd.	Methods for prognosing the ability of a zearalenone analog compound to treat cancer
MX337666B (en) *	2009-10-20	2016-03-14	Nestec Sa	Proximity-mediated assays for detecting oncogenic fusion proteins.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992013870A1 (en) *	1991-01-31	1992-08-20	The Regents Of The University Of California	Human platelet-derived growth factor receptors
WO1995014930A1 (en) *	1993-11-23	1995-06-01	Genentech, Inc.	Kinase receptor activation assay
EP1000617A2 (en) *	1994-01-07	2000-05-17	Sugen, Inc.	Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4376110A (en) *	1980-08-04	1983-03-08	Hybritech, Incorporated	Immunometric assays using monoclonal antibodies
US5045455A (en) *	1984-01-12	1991-09-03	Chiron Corporation	Factor VIII:C cDNA cloning and expression

1994
- 1994-07-29 WO PCT/US1994/008571 patent/WO1995004136A1/en not_active Ceased
- 1994-07-29 CA CA 2166871 patent/CA2166871A1/en not_active Abandoned
- 1994-07-29 SG SG1996005770A patent/SG63596A1/en unknown
- 1994-07-29 EP EP94924067A patent/EP0711341A4/en not_active Withdrawn
- 1994-07-29 JP JP7505992A patent/JPH09501767A/en active Pending
- 1994-07-29 AU AU74080/94A patent/AU7408094A/en not_active Abandoned

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992013870A1 (en) *	1991-01-31	1992-08-20	The Regents Of The University Of California	Human platelet-derived growth factor receptors
WO1995014930A1 (en) *	1993-11-23	1995-06-01	Genentech, Inc.	Kinase receptor activation assay
EP1000617A2 (en) *	1994-01-07	2000-05-17	Sugen, Inc.	Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9504136A1 *

Also Published As

Publication number	Publication date
CA2166871A1 (en)	1995-02-09
JPH09501767A (en)	1997-02-18
SG63596A1 (en)	1999-03-30
EP0711341A1 (en)	1996-05-15
AU7408094A (en)	1995-02-28
WO1995004136A1 (en)	1995-02-09

Publication	Publication Date	Title
EP0705426A4 (en)	1998-07-08	Antigen-specific one-step assays
GB9014903D0 (en)	1990-08-22	Assays
PL314120A1 (en)	1996-11-12	B-adrenergic antagonists
GB9412166D0 (en)	1994-08-10	Retargetting antibodies
GB9517098D0 (en)	1995-10-25	Receptor
GB9614351D0 (en)	1996-09-04	Assay
SG63596A1 (en)	1999-03-30	Receptor function assays
GB9715522D0 (en)	1997-10-01	Assays
EP0719345A4 (en)	1997-07-16	Reagent
GB9606887D0 (en)	1996-06-05	Assay
GB9311854D0 (en)	1993-07-28	Trh receptor action
GB9107983D0 (en)	1991-05-29	Assays
AU6161894A (en)	1994-08-15	Cholecystokinin antagonists
GB9318105D0 (en)	1993-10-20	Receptor action
ZA944336B (en)	1995-02-27	Assay
GB9308544D0 (en)	1993-06-09	Assay
GB9425502D0 (en)	1995-02-15	Novel receptor
GB9304975D0 (en)	1993-04-28	Capture assays
GB9315622D0 (en)	1993-09-08	Assay
GB9307732D0 (en)	1993-06-02	Assay
GB9307659D0 (en)	1993-06-02	Assay
GB9424925D0 (en)	1995-02-15	Immunoassay
GB9416553D0 (en)	1994-10-12	Novel receptor proteins
GB9015353D0 (en)	1990-08-29	Assays
GB9320508D0 (en)	1993-11-24	Antibodies

Legal Events

Date	Code	Title	Description
1996-03-29	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1996-05-15	17P	Request for examination filed	Effective date: 19960115
1996-05-15	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
2001-12-19	A4	Supplementary search report drawn up and despatched	Effective date: 20011102
2001-12-19	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
2001-12-19	RIC1	Information provided on ipc code assigned before grant	Free format text: 7C 12N 9/12 A, 7G 01N 33/53 B, 7G 01N 33/543 B, 7G 01N 33/545 B, 7G 01N 33/573 B, 7G 01N 33/566 B
2004-07-10	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-08-25	18D	Application deemed to be withdrawn	Effective date: 20040202